CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishanian, P.
Right arrow Articles by Fahey, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishanian, P.
Right arrow Articles by Fahey, J. L.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, July 1998, p. 507-512, Vol. 5, No. 4
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Oral Fluids as an Alternative to Serum for Measurement of Markers of Immune Activation

Parunag Nishanian,1,2,3,* Najib Aziz,1 Joanie Chung,1 Roger Detels,2,4 and John L. Fahey1,2,3

Center for Interdisciplinary Research in Immunology and Disease,1 Jonsson Comprehensive Cancer Center,2 School of Medicine,3 and School of Public Health,4 University of California at Los Angeles, Los Angeles, California 90095-1747

Received 23 December 1997/Returned for modification 25 February 1998/Accepted 27 April 1998

Oral fluids are convenient alternatives to blood sampling for evaluating significant metabolic components. Two forms of oral fluids, oral mucosal transudates (OMT) and saliva, were collected and compared for content of soluble products of immune activation. The data confirm that OMT and saliva represent distinct body fluids. The concentrations, outputs, and analyte/protein ratios of beta -2-microglobulin (beta 2M), soluble tumor necrosis factor alpha receptor II (sTNFalpha RII), and neopterin were measured. Both the OMT and the saliva of most of the individuals in the control healthy populations had measurable levels of all three activation markers. When the immune system is activated, as in human immunodeficiency virus (HIV) infection, the levels of beta 2M and sTNFalpha RII are increased in both OMT and saliva compared to those in a healthy control population. OMT levels correlated better with levels in serum than did saliva and appear to reflect systemic immune activation in HIV infection. Because acquisition of oral fluids is noninvasive and easily repeatable, measurement of beta 2M and/or sTNFalpha RII content in OMT could be useful in the assessment of disease activity in patients with HIV infection or chronic inflammatory diseases.


* Corresponding author. Mailing address: CIRID/Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, CA 90095-1747. Phone: (310) 825-1997. Fax: (310) 206-1318. E-mail: DMATHIES{at}microimmun.medsch.ucla.edu.


Clinical and Diagnostic Laboratory Immunology, July 1998, p. 507-512, Vol. 5, No. 4
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.